Rank | Gene Set | Z-score |
---|---|---|
1 | tricarboxylic acid cycle (GO:0006099) | 4.63096166 |
2 | microtubule nucleation (GO:0007020) | 4.21360956 |
3 | positive regulation of mitochondrial fission (GO:0090141) | 4.14784333 |
4 | interkinetic nuclear migration (GO:0022027) | 4.10587204 |
5 | oxaloacetate metabolic process (GO:0006107) | 4.01429659 |
6 | spermatid nucleus differentiation (GO:0007289) | 3.88403278 |
7 | carnitine shuttle (GO:0006853) | 3.86689049 |
8 | actin-mediated cell contraction (GO:0070252) | 3.83586724 |
9 | valine metabolic process (GO:0006573) | 3.83326489 |
10 | NADH metabolic process (GO:0006734) | 3.81727015 |
11 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.80446476 |
12 | oxidative phosphorylation (GO:0006119) | 3.80442816 |
13 | lysine metabolic process (GO:0006553) | 3.73533531 |
14 | lysine catabolic process (GO:0006554) | 3.73533531 |
15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.72104152 |
16 | DNA deamination (GO:0045006) | 3.70351558 |
17 | behavioral response to nicotine (GO:0035095) | 3.69440993 |
18 | galactose catabolic process (GO:0019388) | 3.68198884 |
19 | purine nucleotide salvage (GO:0032261) | 3.67467863 |
20 | regulation of meiosis I (GO:0060631) | 3.65976521 |
21 | neural tube formation (GO:0001841) | 3.64576052 |
22 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61504150 |
23 | response to inactivity (GO:0014854) | 3.56335757 |
24 | protein polyglutamylation (GO:0018095) | 3.46948771 |
25 | establishment of mitochondrion localization (GO:0051654) | 3.45676962 |
26 | negative regulation of cell size (GO:0045792) | 3.39344128 |
27 | regulation of translational termination (GO:0006449) | 3.39337494 |
28 | microtubule severing (GO:0051013) | 3.37186967 |
29 | protein retention in ER lumen (GO:0006621) | 3.33876928 |
30 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.33143258 |
31 | pyrimidine dimer repair (GO:0006290) | 3.32019281 |
32 | fatty acid transmembrane transport (GO:1902001) | 3.31401578 |
33 | purine-containing compound salvage (GO:0043101) | 3.25104771 |
34 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.24007426 |
35 | photoreceptor cell differentiation (GO:0046530) | 3.23450261 |
36 | eye photoreceptor cell differentiation (GO:0001754) | 3.23450261 |
37 | regulation of skeletal muscle contraction (GO:0014819) | 3.22366946 |
38 | seminiferous tubule development (GO:0072520) | 3.22143218 |
39 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.21010570 |
40 | IMP metabolic process (GO:0046040) | 3.20395110 |
41 | myofibril assembly (GO:0030239) | 3.19265958 |
42 | dosage compensation (GO:0007549) | 3.17424571 |
43 | tricarboxylic acid metabolic process (GO:0072350) | 3.17069198 |
44 | adenosine metabolic process (GO:0046085) | 3.14723930 |
45 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.13745841 |
46 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.13745841 |
47 | aspartate family amino acid catabolic process (GO:0009068) | 3.12977798 |
48 | nucleotide salvage (GO:0043173) | 3.11420457 |
49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11360288 |
50 | piRNA metabolic process (GO:0034587) | 3.10801336 |
51 | regulation of female gonad development (GO:2000194) | 3.09858526 |
52 | regulation of cofactor metabolic process (GO:0051193) | 3.09730545 |
53 | regulation of coenzyme metabolic process (GO:0051196) | 3.09730545 |
54 | COPI coating of Golgi vesicle (GO:0048205) | 3.09396723 |
55 | Golgi transport vesicle coating (GO:0048200) | 3.09396723 |
56 | sarcomere organization (GO:0045214) | 3.09318124 |
57 | carnitine transmembrane transport (GO:1902603) | 3.09075976 |
58 | folic acid metabolic process (GO:0046655) | 3.08075320 |
59 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.07135541 |
60 | negative regulation of neurotransmitter transport (GO:0051589) | 3.05723285 |
61 | DNA double-strand break processing (GO:0000729) | 3.04811103 |
62 | striatum development (GO:0021756) | 3.03871212 |
63 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.01661851 |
64 | AMP metabolic process (GO:0046033) | 2.98297255 |
65 | CENP-A containing nucleosome assembly (GO:0034080) | 2.95293140 |
66 | chromatin remodeling at centromere (GO:0031055) | 2.94816615 |
67 | regulation of relaxation of muscle (GO:1901077) | 2.94544599 |
68 | ubiquinone biosynthetic process (GO:0006744) | 2.93841048 |
69 | quinone biosynthetic process (GO:1901663) | 2.93841048 |
70 | skeletal muscle tissue regeneration (GO:0043403) | 2.93729385 |
71 | regulation of histone H3-K9 methylation (GO:0051570) | 2.92060828 |
72 | reciprocal DNA recombination (GO:0035825) | 2.91756424 |
73 | reciprocal meiotic recombination (GO:0007131) | 2.91756424 |
74 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.91548314 |
75 | cysteine metabolic process (GO:0006534) | 2.91070031 |
76 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.90951572 |
77 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.90564198 |
78 | heme biosynthetic process (GO:0006783) | 2.90351051 |
79 | succinate metabolic process (GO:0006105) | 2.90073202 |
80 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.90069725 |
81 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.88771117 |
82 | synapsis (GO:0007129) | 2.87762100 |
83 | centriole replication (GO:0007099) | 2.87537233 |
84 | amino-acid betaine transport (GO:0015838) | 2.87195196 |
85 | carnitine transport (GO:0015879) | 2.87195196 |
86 | regulation of fatty acid oxidation (GO:0046320) | 2.86975920 |
87 | neuron fate determination (GO:0048664) | 2.86666207 |
88 | IMP biosynthetic process (GO:0006188) | 2.85684885 |
89 | protein K48-linked ubiquitination (GO:0070936) | 2.83165211 |
90 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.83073577 |
91 | establishment of protein localization to Golgi (GO:0072600) | 2.82632232 |
92 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.81428211 |
93 | aspartate family amino acid metabolic process (GO:0009066) | 2.80464624 |
94 | nucleus localization (GO:0051647) | 2.76831009 |
95 | histone H3-K9 methylation (GO:0051567) | 2.76585674 |
96 | mitochondrion transport along microtubule (GO:0047497) | 2.74782202 |
97 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.74782202 |
98 | actin filament-based movement (GO:0030048) | 2.74437438 |
99 | skeletal muscle contraction (GO:0003009) | 2.73521865 |
100 | somite rostral/caudal axis specification (GO:0032525) | 2.72511176 |
101 | tetrapyrrole biosynthetic process (GO:0033014) | 2.72444434 |
102 | DNA strand elongation (GO:0022616) | 2.71878528 |
103 | purine nucleobase metabolic process (GO:0006144) | 2.71160995 |
104 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.70033683 |
105 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.69662200 |
106 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.69637273 |
107 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.69520277 |
108 | single strand break repair (GO:0000012) | 2.69190026 |
109 | microtubule anchoring (GO:0034453) | 2.68267815 |
110 | translesion synthesis (GO:0019985) | 2.65017635 |
111 | cellular metabolic compound salvage (GO:0043094) | 2.64442098 |
112 | mitochondrial calcium ion transport (GO:0006851) | 2.64301978 |
113 | nerve growth factor signaling pathway (GO:0038180) | 2.63122699 |
114 | protein K63-linked deubiquitination (GO:0070536) | 2.62836025 |
115 | amino acid salvage (GO:0043102) | 2.61055249 |
116 | L-methionine salvage (GO:0071267) | 2.61055249 |
117 | L-methionine biosynthetic process (GO:0071265) | 2.61055249 |
118 | cardiac myofibril assembly (GO:0055003) | 2.59982794 |
119 | DNA unwinding involved in DNA replication (GO:0006268) | 2.59957909 |
120 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.59401565 |
121 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.59062789 |
122 | branched-chain amino acid catabolic process (GO:0009083) | 2.58907372 |
123 | sex differentiation (GO:0007548) | 2.58578307 |
124 | DNA replication initiation (GO:0006270) | 2.58560394 |
125 | regulation of sulfur metabolic process (GO:0042762) | 2.57805940 |
126 | positive regulation of myoblast differentiation (GO:0045663) | 2.57089493 |
127 | mitochondrial fusion (GO:0008053) | 2.56605106 |
128 | branched-chain amino acid metabolic process (GO:0009081) | 2.54342977 |
129 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.53631899 |
130 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.52472481 |
131 | glycine metabolic process (GO:0006544) | 2.52330416 |
132 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.51920117 |
133 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.51181736 |
134 | cellular hyperosmotic response (GO:0071474) | 2.50102741 |
135 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.49617239 |
136 | carnitine metabolic process (GO:0009437) | 2.49369315 |
137 | regulation of sarcomere organization (GO:0060297) | 2.49337001 |
138 | protein targeting to Golgi (GO:0000042) | 2.49232249 |
139 | fatty acid beta-oxidation (GO:0006635) | 2.49079114 |
140 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.48546446 |
141 | muscle filament sliding (GO:0030049) | 2.47613486 |
142 | actin-myosin filament sliding (GO:0033275) | 2.47613486 |
143 | inositol metabolic process (GO:0006020) | 2.47428736 |
144 | sulfur amino acid catabolic process (GO:0000098) | 2.47189370 |
145 | postreplication repair (GO:0006301) | 2.47001373 |
146 | ADP metabolic process (GO:0046031) | 2.46658193 |
147 | inositol phosphate catabolic process (GO:0071545) | 2.46641749 |
148 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.46533920 |
149 | positive regulation of lamellipodium assembly (GO:0010592) | 2.45289658 |
150 | one-carbon metabolic process (GO:0006730) | 2.45113763 |
151 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.45110496 |
152 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.44710863 |
153 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.44250130 |
154 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.44003237 |
155 | iron-sulfur cluster assembly (GO:0016226) | 2.43328762 |
156 | metallo-sulfur cluster assembly (GO:0031163) | 2.43328762 |
157 | protein complex localization (GO:0031503) | 2.43326788 |
158 | synaptic transmission, cholinergic (GO:0007271) | 2.43279761 |
159 | cardiac muscle hypertrophy (GO:0003300) | 2.43263633 |
160 | sulfur amino acid biosynthetic process (GO:0000097) | 2.42920208 |
161 | striated muscle contraction (GO:0006941) | 2.42781849 |
162 | negative regulation of potassium ion transport (GO:0043267) | 2.42738091 |
163 | response to caffeine (GO:0031000) | 2.42661129 |
164 | histone exchange (GO:0043486) | 2.41003360 |
165 | GDP-mannose metabolic process (GO:0019673) | 2.40769073 |
166 | regulation of DNA endoreduplication (GO:0032875) | 2.40537185 |
167 | methionine metabolic process (GO:0006555) | 2.40267265 |
168 | gluconeogenesis (GO:0006094) | 2.40208764 |
169 | amino-acid betaine metabolic process (GO:0006577) | 2.39536919 |
170 | glycogen catabolic process (GO:0005980) | 2.38926690 |
171 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.38492452 |
172 | negative regulation of necroptotic process (GO:0060546) | 2.38469997 |
173 | gene silencing by RNA (GO:0031047) | 2.38343416 |
174 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.38241063 |
175 | heart contraction (GO:0060047) | 2.38207484 |
176 | heart process (GO:0003015) | 2.38207484 |
177 | peptidyl-lysine methylation (GO:0018022) | 2.37956194 |
178 | regulation of mitochondrial fission (GO:0090140) | 2.37917769 |
179 | 4-hydroxyproline metabolic process (GO:0019471) | 2.37058709 |
180 | tachykinin receptor signaling pathway (GO:0007217) | 2.36866965 |
181 | nucleoside salvage (GO:0043174) | 2.36667512 |
182 | hexose biosynthetic process (GO:0019319) | 2.36526762 |
183 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.36263990 |
184 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.36263990 |
185 | peptidyl-lysine dimethylation (GO:0018027) | 2.34590963 |
186 | regulation of pigment cell differentiation (GO:0050932) | 2.33717517 |
187 | mitotic G2/M transition checkpoint (GO:0044818) | 2.33702894 |
188 | inositol phosphate dephosphorylation (GO:0046855) | 2.33613314 |
189 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.33613314 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.09492491 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.13793677 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.02800028 |
4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.73099903 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.98683296 |
6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.92561353 |
7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.88986073 |
8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.86505266 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83315292 |
10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.80776227 |
11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.78362347 |
12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.65948810 |
13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.65273326 |
14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59777995 |
15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.52323297 |
16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.45487304 |
17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.42158589 |
18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.39735363 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 2.35853053 |
20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.31026272 |
21 | EWS_26573619_Chip-Seq_HEK293_Human | 2.30414918 |
22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.27619215 |
23 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.17211698 |
24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.04348094 |
25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04157784 |
26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.03424639 |
27 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02202261 |
28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01828226 |
29 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.97742921 |
30 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93149419 |
31 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.92470423 |
32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91463276 |
33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.87928256 |
34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81222715 |
35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.80902216 |
36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80721376 |
37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.79263229 |
38 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.78552233 |
39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.76531213 |
40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76057009 |
41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75206385 |
42 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.74590235 |
43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74333599 |
44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71079781 |
45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.69057603 |
46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68168461 |
47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65988600 |
48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65957545 |
49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65819810 |
50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.65445781 |
51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.65445781 |
52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65287812 |
53 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.65243874 |
54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65235974 |
55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.62821454 |
56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.59506058 |
57 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.59291863 |
58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58702225 |
59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58634947 |
60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.56634708 |
61 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.56388697 |
62 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56177244 |
63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55734485 |
64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55488660 |
65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53009370 |
66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.50834244 |
67 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49772293 |
68 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.48510914 |
69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.48213146 |
70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48147150 |
71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47184256 |
72 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46281500 |
73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46133363 |
74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45717535 |
75 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.45662174 |
76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44748685 |
77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43890450 |
78 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42953420 |
79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.42676954 |
80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42323059 |
81 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42211767 |
82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41715769 |
83 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41528702 |
84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41211398 |
85 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.40835698 |
86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39981190 |
87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38380309 |
88 | * P68_20966046_ChIP-Seq_HELA_Human | 1.38187114 |
89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36678174 |
90 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.35830901 |
91 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34106125 |
92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33823892 |
93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33234801 |
94 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31974088 |
95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.31966804 |
96 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30950238 |
97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30757756 |
98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29722094 |
99 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28514092 |
100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28436396 |
101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.28224740 |
102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27141201 |
103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26294011 |
104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26240844 |
105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25622122 |
106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.25504107 |
107 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25487550 |
108 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23635047 |
109 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.23090818 |
110 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23068465 |
111 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22732103 |
112 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22205617 |
113 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.22128349 |
114 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21665106 |
115 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21636354 |
116 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20795966 |
117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20708920 |
118 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20337191 |
119 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20229204 |
120 | MAF_26560356_Chip-Seq_TH1_Human | 1.19690612 |
121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18948439 |
122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18761111 |
123 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18600001 |
124 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18590581 |
125 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18556692 |
126 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.18525557 |
127 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18511419 |
128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17904317 |
129 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17693087 |
130 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.17504424 |
131 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17120007 |
132 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16841597 |
133 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16814946 |
134 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16810746 |
135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16810746 |
136 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16088210 |
137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15744608 |
138 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15109029 |
139 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14976290 |
140 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14828764 |
141 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14633950 |
142 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.14429176 |
143 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.14172307 |
144 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.13535611 |
145 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13439435 |
146 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.13298387 |
147 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12340341 |
148 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11558305 |
149 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11428665 |
150 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11393156 |
151 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11220254 |
152 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10721774 |
153 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10664395 |
154 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10437591 |
155 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10366040 |
156 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10191151 |
157 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10137778 |
158 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08829027 |
159 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08775265 |
160 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08299047 |
161 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08249307 |
162 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08159703 |
163 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.07533874 |
164 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07235111 |
165 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07163808 |
166 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06786136 |
167 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06200015 |
168 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05785645 |
169 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05242812 |
170 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05129435 |
171 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04138680 |
172 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04092472 |
173 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03775692 |
174 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03254553 |
175 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02658022 |
176 | MAF_26560356_Chip-Seq_TH2_Human | 1.02359454 |
177 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02115264 |
178 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.01989455 |
179 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01883556 |
180 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01758876 |
181 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01618591 |
182 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01525535 |
183 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01381837 |
184 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01298710 |
185 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.01267885 |
186 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00662465 |
187 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00067339 |
188 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98212189 |
189 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98151333 |
190 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98151333 |
191 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.97894790 |
192 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95246394 |
193 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95067212 |
194 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.94645498 |
195 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93929580 |
196 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93013842 |
197 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.92292644 |
198 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92002686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 5.12739961 |
2 | MP0000569_abnormal_digit_pigmentation | 5.11280400 |
3 | MP0003656_abnormal_erythrocyte_physiolo | 3.43074218 |
4 | MP0002837_dystrophic_cardiac_calcinosis | 3.20927513 |
5 | MP0003806_abnormal_nucleotide_metabolis | 3.07193379 |
6 | MP0000751_myopathy | 2.71000374 |
7 | MP0000749_muscle_degeneration | 2.62578601 |
8 | MP0006036_abnormal_mitochondrial_physio | 2.52747599 |
9 | MP0005365_abnormal_bile_salt | 2.48839178 |
10 | MP0004147_increased_porphyrin_level | 2.46712763 |
11 | MP0005083_abnormal_biliary_tract | 2.40709836 |
12 | MP0008995_early_reproductive_senescence | 2.40031655 |
13 | MP0000372_irregular_coat_pigmentation | 2.35978976 |
14 | MP0004130_abnormal_muscle_cell | 2.30973981 |
15 | MP0004084_abnormal_cardiac_muscle | 2.30400682 |
16 | MP0002396_abnormal_hematopoietic_system | 2.27658958 |
17 | MP0006292_abnormal_olfactory_placode | 2.17415265 |
18 | MP0002269_muscular_atrophy | 2.14548425 |
19 | MP0004036_abnormal_muscle_relaxation | 2.13472173 |
20 | MP0004233_abnormal_muscle_weight | 2.03828365 |
21 | MP0001529_abnormal_vocalization | 2.03322404 |
22 | MP0004215_abnormal_myocardial_fiber | 2.01766622 |
23 | MP0005085_abnormal_gallbladder_physiolo | 2.01112626 |
24 | MP0003890_abnormal_embryonic-extraembry | 1.95279575 |
25 | MP0005397_hematopoietic_system_phenotyp | 1.90052234 |
26 | MP0001545_abnormal_hematopoietic_system | 1.90052234 |
27 | MP0002139_abnormal_hepatobiliary_system | 1.87617499 |
28 | MP0002009_preneoplasia | 1.87139846 |
29 | MP0003693_abnormal_embryo_hatching | 1.85052192 |
30 | MP0004087_abnormal_muscle_fiber | 1.83582121 |
31 | MP0001984_abnormal_olfaction | 1.79657418 |
32 | MP0002102_abnormal_ear_morphology | 1.78548423 |
33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.76227693 |
34 | MP0000747_muscle_weakness | 1.72568065 |
35 | MP0004145_abnormal_muscle_electrophysio | 1.71858541 |
36 | MP0002234_abnormal_pharynx_morphology | 1.70514700 |
37 | MP0002095_abnormal_skin_pigmentation | 1.69865769 |
38 | MP0004142_abnormal_muscle_tone | 1.67857744 |
39 | MP0005670_abnormal_white_adipose | 1.65927374 |
40 | MP0002106_abnormal_muscle_physiology | 1.64063162 |
41 | MP0009840_abnormal_foam_cell | 1.64012489 |
42 | MP0010094_abnormal_chromosome_stability | 1.61223051 |
43 | MP0006035_abnormal_mitochondrial_morpho | 1.60906228 |
44 | MP0002127_abnormal_cardiovascular_syste | 1.55668753 |
45 | MP0001666_abnormal_nutrient_absorption | 1.54700740 |
46 | MP0003122_maternal_imprinting | 1.54674577 |
47 | MP0005330_cardiomyopathy | 1.52989821 |
48 | MP0005423_abnormal_somatic_nervous | 1.51864918 |
49 | MP0003186_abnormal_redox_activity | 1.51412305 |
50 | MP0005174_abnormal_tail_pigmentation | 1.48078402 |
51 | MP0008057_abnormal_DNA_replication | 1.47757060 |
52 | MP0003121_genomic_imprinting | 1.40931268 |
53 | MP0005319_abnormal_enzyme/_coenzyme | 1.40187270 |
54 | MP0000015_abnormal_ear_pigmentation | 1.39115827 |
55 | MP0000759_abnormal_skeletal_muscle | 1.38510577 |
56 | MP0004134_abnormal_chest_morphology | 1.37625873 |
57 | MP0000343_altered_response_to | 1.33342626 |
58 | MP0005360_urolithiasis | 1.29232118 |
59 | MP0008789_abnormal_olfactory_epithelium | 1.29155780 |
60 | MP0002822_catalepsy | 1.28625276 |
61 | MP0000750_abnormal_muscle_regeneration | 1.24526609 |
62 | MP0004808_abnormal_hematopoietic_stem | 1.24477072 |
63 | MP0000013_abnormal_adipose_tissue | 1.24388430 |
64 | MP0003183_abnormal_peptide_metabolism | 1.24063064 |
65 | MP0010630_abnormal_cardiac_muscle | 1.23971285 |
66 | MP0004957_abnormal_blastocyst_morpholog | 1.23926119 |
67 | MP0004133_heterotaxia | 1.20965223 |
68 | MP0005394_taste/olfaction_phenotype | 1.20437711 |
69 | MP0005499_abnormal_olfactory_system | 1.20437711 |
70 | MP0003111_abnormal_nucleus_morphology | 1.20153827 |
71 | MP0000631_abnormal_neuroendocrine_gland | 1.16231348 |
72 | MP0003787_abnormal_imprinting | 1.15882908 |
73 | MP0005369_muscle_phenotype | 1.15494251 |
74 | MP0003705_abnormal_hypodermis_morpholog | 1.14384249 |
75 | MP0005620_abnormal_muscle_contractility | 1.13647119 |
76 | MP0010352_gastrointestinal_tract_polyps | 1.11175681 |
77 | MP0010329_abnormal_lipoprotein_level | 1.09321596 |
78 | MP0001544_abnormal_cardiovascular_syste | 1.08943858 |
79 | MP0005385_cardiovascular_system_phenoty | 1.08943858 |
80 | MP0008775_abnormal_heart_ventricle | 1.08754933 |
81 | MP0000490_abnormal_crypts_of | 1.08454164 |
82 | MP0002938_white_spotting | 1.08255991 |
83 | MP0003191_abnormal_cellular_cholesterol | 1.08188224 |
84 | MP0003077_abnormal_cell_cycle | 1.07050177 |
85 | MP0005666_abnormal_adipose_tissue | 1.06047230 |
86 | MP0009250_abnormal_appendicular_skeleto | 1.05791285 |
87 | MP0005464_abnormal_platelet_physiology | 1.05784238 |
88 | MP0002653_abnormal_ependyma_morphology | 1.03023392 |
89 | * MP0000358_abnormal_cell_content/ | 1.02848990 |
90 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02667205 |
91 | MP0006054_spinal_hemorrhage | 1.01344122 |
92 | MP0005266_abnormal_metabolism | 1.00288887 |
93 | MP0000049_abnormal_middle_ear | 0.99805316 |
94 | MP0002972_abnormal_cardiac_muscle | 0.99369520 |
95 | MP0003698_abnormal_male_reproductive | 0.98253984 |
96 | MP0008961_abnormal_basal_metabolism | 0.97844735 |
97 | MP0000609_abnormal_liver_physiology | 0.95654178 |
98 | MP0006276_abnormal_autonomic_nervous | 0.95593390 |
99 | MP0001764_abnormal_homeostasis | 0.95466405 |
100 | MP0001873_stomach_inflammation | 0.92317786 |
101 | MP0002118_abnormal_lipid_homeostasis | 0.92167415 |
102 | MP0003763_abnormal_thymus_physiology | 0.91704273 |
103 | MP0005332_abnormal_amino_acid | 0.90317361 |
104 | MP0000685_abnormal_immune_system | 0.90307338 |
105 | MP0002177_abnormal_outer_ear | 0.89375398 |
106 | MP0003137_abnormal_impulse_conducting | 0.87333937 |
107 | MP0005171_absent_coat_pigmentation | 0.86951521 |
108 | MP0002735_abnormal_chemical_nociception | 0.86544720 |
109 | MP0002019_abnormal_tumor_incidence | 0.86330925 |
110 | MP0001177_atelectasis | 0.85635324 |
111 | MP0000778_abnormal_nervous_system | 0.85372212 |
112 | MP0005551_abnormal_eye_electrophysiolog | 0.84668668 |
113 | MP0005386_behavior/neurological_phenoty | 0.84418638 |
114 | MP0004924_abnormal_behavior | 0.84418638 |
115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84189053 |
116 | MP0002928_abnormal_bile_duct | 0.83986421 |
117 | MP0010030_abnormal_orbit_morphology | 0.83543438 |
118 | MP0000598_abnormal_liver_morphology | 0.83295672 |
119 | MP0001929_abnormal_gametogenesis | 0.83124664 |
120 | MP0002398_abnormal_bone_marrow | 0.82409014 |
121 | MP0004484_altered_response_of | 0.81995647 |
122 | MP0005253_abnormal_eye_physiology | 0.81843495 |
123 | MP0002233_abnormal_nose_morphology | 0.81819769 |
124 | MP0002210_abnormal_sex_determination | 0.80679570 |
125 | MP0002108_abnormal_muscle_morphology | 0.79964653 |
126 | MP0003937_abnormal_limbs/digits/tail_de | 0.79785763 |
127 | MP0005075_abnormal_melanosome_morpholog | 0.77915139 |
128 | MP0001730_embryonic_growth_arrest | 0.77379101 |
129 | MP0005410_abnormal_fertilization | 0.77047986 |
130 | MP0002970_abnormal_white_adipose | 0.76892606 |
131 | MP0005220_abnormal_exocrine_pancreas | 0.76793313 |
132 | MP0001324_abnormal_eye_pigmentation | 0.76430021 |
133 | MP0010368_abnormal_lymphatic_system | 0.76098562 |
134 | MP0003868_abnormal_feces_composition | 0.75772668 |
135 | MP0008058_abnormal_DNA_repair | 0.74832979 |
136 | MP0001293_anophthalmia | 0.72628659 |
137 | MP0002078_abnormal_glucose_homeostasis | 0.72370941 |
138 | MP0000313_abnormal_cell_death | 0.71765908 |
139 | MP0009643_abnormal_urine_homeostasis | 0.71343971 |
140 | MP0002332_abnormal_exercise_endurance | 0.71231018 |
141 | MP0000653_abnormal_sex_gland | 0.71043922 |
142 | MP0000689_abnormal_spleen_morphology | 0.70927085 |
143 | MP0002272_abnormal_nervous_system | 0.70671661 |
144 | MP0000733_abnormal_muscle_development | 0.69880409 |
145 | MP0002638_abnormal_pupillary_reflex | 0.69711117 |
146 | MP0005645_abnormal_hypothalamus_physiol | 0.69513913 |
147 | MP0001986_abnormal_taste_sensitivity | 0.69399678 |
148 | MP0002080_prenatal_lethality | 0.67403756 |
149 | MP0008877_abnormal_DNA_methylation | 0.67044031 |
150 | MP0003880_abnormal_central_pattern | 0.66907929 |
151 | MP0004185_abnormal_adipocyte_glucose | 0.66555988 |
152 | MP0008004_abnormal_stomach_pH | 0.66477740 |
153 | MP0003567_abnormal_fetal_cardiomyocyte | 0.66229782 |
154 | MP0002722_abnormal_immune_system | 0.65784866 |
155 | MP0002751_abnormal_autonomic_nervous | 0.65726059 |
156 | MP0005636_abnormal_mineral_homeostasis | 0.65592133 |
157 | MP0002249_abnormal_larynx_morphology | 0.65447776 |
158 | MP0002429_abnormal_blood_cell | 0.65049548 |
159 | MP0003136_yellow_coat_color | 0.64936329 |
160 | MP0003635_abnormal_synaptic_transmissio | 0.64174808 |
161 | MP0000350_abnormal_cell_proliferation | 0.64170163 |
162 | MP0004264_abnormal_extraembryonic_tissu | 0.63162553 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 4.42068313 |
2 | Myoglobinuria (HP:0002913) | 4.30991600 |
3 | Rhabdomyolysis (HP:0003201) | 4.15285135 |
4 | Exercise-induced muscle cramps (HP:0003710) | 4.10884588 |
5 | Aplastic anemia (HP:0001915) | 3.58605797 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 3.51652265 |
7 | Abnormality of alanine metabolism (HP:0010916) | 3.37571201 |
8 | Hyperalaninemia (HP:0003348) | 3.37571201 |
9 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.37571201 |
10 | Medial flaring of the eyebrow (HP:0010747) | 3.31677417 |
11 | Asymmetric septal hypertrophy (HP:0001670) | 3.29820864 |
12 | Rimmed vacuoles (HP:0003805) | 3.25397817 |
13 | Gait imbalance (HP:0002141) | 3.17093217 |
14 | Congenital primary aphakia (HP:0007707) | 3.05966696 |
15 | Nephrogenic diabetes insipidus (HP:0009806) | 3.01772749 |
16 | Hyperammonemia (HP:0001987) | 2.99758824 |
17 | Sudden death (HP:0001699) | 2.96807448 |
18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.94506856 |
19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.94506856 |
20 | Ulnar deviation of the wrist (HP:0003049) | 2.88935333 |
21 | Drooling (HP:0002307) | 2.88504719 |
22 | Myotonia (HP:0002486) | 2.84669703 |
23 | Long clavicles (HP:0000890) | 2.83168327 |
24 | Subaortic stenosis (HP:0001682) | 2.81616264 |
25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.81616264 |
26 | Bundle branch block (HP:0011710) | 2.81184873 |
27 | Myopathic facies (HP:0002058) | 2.80285209 |
28 | Palpitations (HP:0001962) | 2.80266790 |
29 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.79181642 |
30 | Ventricular tachycardia (HP:0004756) | 2.78652602 |
31 | Poor coordination (HP:0002370) | 2.76966210 |
32 | Muscle stiffness (HP:0003552) | 2.76482157 |
33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.75836389 |
34 | Dicarboxylic aciduria (HP:0003215) | 2.74836930 |
35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.74836930 |
36 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.74590835 |
37 | Ketosis (HP:0001946) | 2.71594334 |
38 | Increased muscle lipid content (HP:0009058) | 2.68027787 |
39 | Calf muscle hypertrophy (HP:0008981) | 2.60825164 |
40 | Genital tract atresia (HP:0001827) | 2.58576944 |
41 | Excessive salivation (HP:0003781) | 2.58250566 |
42 | Gout (HP:0001997) | 2.55691892 |
43 | Hepatic necrosis (HP:0002605) | 2.54666545 |
44 | Hyporeflexia of lower limbs (HP:0002600) | 2.53087327 |
45 | Distal arthrogryposis (HP:0005684) | 2.51790447 |
46 | Vaginal atresia (HP:0000148) | 2.51717415 |
47 | Atrioventricular block (HP:0001678) | 2.51629270 |
48 | Muscle fiber splitting (HP:0003555) | 2.47254865 |
49 | Areflexia of lower limbs (HP:0002522) | 2.45004963 |
50 | Poikilocytosis (HP:0004447) | 2.44024870 |
51 | Chronic hepatic failure (HP:0100626) | 2.41629202 |
52 | Ragged-red muscle fibers (HP:0003200) | 2.41168896 |
53 | Hypoglycemic coma (HP:0001325) | 2.39770807 |
54 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.39588339 |
55 | Heart block (HP:0012722) | 2.38518644 |
56 | Ketoacidosis (HP:0001993) | 2.35350772 |
57 | Lipoatrophy (HP:0100578) | 2.34951330 |
58 | Difficulty running (HP:0009046) | 2.33990922 |
59 | Difficulty climbing stairs (HP:0003551) | 2.33462524 |
60 | Muscle fiber inclusion bodies (HP:0100299) | 2.32184646 |
61 | Late onset (HP:0003584) | 2.31345682 |
62 | Lactic acidosis (HP:0003128) | 2.28156840 |
63 | Abnormality of the calf musculature (HP:0001430) | 2.26618009 |
64 | Polycythemia (HP:0001901) | 2.25506342 |
65 | Cortical dysplasia (HP:0002539) | 2.24169110 |
66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.24125041 |
67 | Abnormal finger flexion creases (HP:0006143) | 2.24024209 |
68 | Hepatocellular necrosis (HP:0001404) | 2.23344900 |
69 | Neoplasm of head and neck (HP:0012288) | 2.21075493 |
70 | Esophageal neoplasm (HP:0100751) | 2.21075493 |
71 | Truncal obesity (HP:0001956) | 2.20277023 |
72 | Cholelithiasis (HP:0001081) | 2.19961735 |
73 | Ventricular fibrillation (HP:0001663) | 2.19458986 |
74 | * Hypoplastic iliac wings (HP:0002866) | 2.17396195 |
75 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15159677 |
76 | Progressive muscle weakness (HP:0003323) | 2.14646548 |
77 | Hyperbilirubinemia (HP:0002904) | 2.14525075 |
78 | Abnormal atrioventricular conduction (HP:0005150) | 2.14061729 |
79 | Genetic anticipation (HP:0003743) | 2.13592016 |
80 | Abnormality of the labia minora (HP:0012880) | 2.12794124 |
81 | Abnormality of the lower motor neuron (HP:0002366) | 2.12419399 |
82 | Papillary thyroid carcinoma (HP:0002895) | 2.11743319 |
83 | Limb-girdle muscle atrophy (HP:0003797) | 2.11607310 |
84 | Colon cancer (HP:0003003) | 2.10811156 |
85 | Left ventricular hypertrophy (HP:0001712) | 2.10400625 |
86 | Thrombocytosis (HP:0001894) | 2.10256602 |
87 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.09794243 |
88 | Thyroid-stimulating hormone excess (HP:0002925) | 2.08779591 |
89 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.08346124 |
90 | Dilated cardiomyopathy (HP:0001644) | 2.07984218 |
91 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05161036 |
92 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05161036 |
93 | Central scotoma (HP:0000603) | 2.04022285 |
94 | Acanthocytosis (HP:0001927) | 2.03834712 |
95 | Type II lissencephaly (HP:0007260) | 2.03243081 |
96 | Absent phalangeal crease (HP:0006109) | 2.02940587 |
97 | Oligodactyly (hands) (HP:0001180) | 2.02159268 |
98 | EMG: myopathic abnormalities (HP:0003458) | 2.01593630 |
99 | Increased connective tissue (HP:0009025) | 2.00968443 |
100 | Reticulocytosis (HP:0001923) | 2.00285786 |
101 | Abnormality of the nasal mucosa (HP:0000433) | 1.96644577 |
102 | Short foot (HP:0001773) | 1.94631053 |
103 | Lissencephaly (HP:0001339) | 1.93716973 |
104 | Calcaneovalgus deformity (HP:0001848) | 1.93005800 |
105 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92825132 |
106 | Broad-based gait (HP:0002136) | 1.91928458 |
107 | Poor eye contact (HP:0000817) | 1.91924879 |
108 | Long toe (HP:0010511) | 1.91701244 |
109 | Hyperglycinuria (HP:0003108) | 1.90820662 |
110 | Attenuation of retinal blood vessels (HP:0007843) | 1.90265127 |
111 | Nephronophthisis (HP:0000090) | 1.89847877 |
112 | Acute lymphatic leukemia (HP:0006721) | 1.89154719 |
113 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.89055949 |
114 | Urinary urgency (HP:0000012) | 1.88801306 |
115 | Hyperglycinemia (HP:0002154) | 1.88152639 |
116 | Generalized aminoaciduria (HP:0002909) | 1.86767084 |
117 | Increased purine levels (HP:0004368) | 1.86731479 |
118 | Hyperuricemia (HP:0002149) | 1.86731479 |
119 | Supraventricular tachycardia (HP:0004755) | 1.86215837 |
120 | Pachygyria (HP:0001302) | 1.85872070 |
121 | Abnormal gallbladder morphology (HP:0012437) | 1.85514287 |
122 | * Abnormality of the pubic bones (HP:0003172) | 1.85130217 |
123 | Nasal polyposis (HP:0100582) | 1.84813057 |
124 | Nemaline bodies (HP:0003798) | 1.84665494 |
125 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.84020973 |
126 | Pancreatic cysts (HP:0001737) | 1.83973479 |
127 | Abnormality of the corticospinal tract (HP:0002492) | 1.83452739 |
128 | Abnormality of lateral ventricle (HP:0030047) | 1.83356320 |
129 | Atrial fibrillation (HP:0005110) | 1.83116392 |
130 | Cholecystitis (HP:0001082) | 1.83077962 |
131 | Abnormal gallbladder physiology (HP:0012438) | 1.83077962 |
132 | Progressive cerebellar ataxia (HP:0002073) | 1.82991542 |
133 | Neuroendocrine neoplasm (HP:0100634) | 1.81539621 |
134 | Hip dysplasia (HP:0001385) | 1.81347430 |
135 | Hypoplasia of the pons (HP:0012110) | 1.80868497 |
136 | Primary atrial arrhythmia (HP:0001692) | 1.80390013 |
137 | Prolonged QT interval (HP:0001657) | 1.80321560 |
138 | Tubulointerstitial nephritis (HP:0001970) | 1.80233037 |
139 | Muscle fiber atrophy (HP:0100295) | 1.79899792 |
140 | Unsteady gait (HP:0002317) | 1.79791690 |
141 | Increased serum ferritin (HP:0003281) | 1.79440858 |
142 | Petechiae (HP:0000967) | 1.78980464 |
143 | Metabolic acidosis (HP:0001942) | 1.78532501 |
144 | Toxemia of pregnancy (HP:0100603) | 1.76631795 |
145 | Pheochromocytoma (HP:0002666) | 1.76407596 |
146 | Supraventricular arrhythmia (HP:0005115) | 1.76289275 |
147 | Syncope (HP:0001279) | 1.76018542 |
148 | Oligomenorrhea (HP:0000876) | 1.75673731 |
149 | Gaze-evoked nystagmus (HP:0000640) | 1.75587869 |
150 | Ectopic kidney (HP:0000086) | 1.75549079 |
151 | Spastic paraplegia (HP:0001258) | 1.75456453 |
152 | * Broad foot (HP:0001769) | 1.75144861 |
153 | Hypoalphalipoproteinemia (HP:0003233) | 1.73953756 |
154 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.73609018 |
155 | Specific learning disability (HP:0001328) | 1.72231643 |
156 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.72123917 |
157 | Fetal akinesia sequence (HP:0001989) | 1.70371847 |
158 | Chromsome breakage (HP:0040012) | 1.69656122 |
159 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.69198289 |
160 | Impulsivity (HP:0100710) | 1.68602238 |
161 | Cerebellar dysplasia (HP:0007033) | 1.68185983 |
162 | True hermaphroditism (HP:0010459) | 1.66706858 |
163 | Tented upper lip vermilion (HP:0010804) | 1.65280817 |
164 | Astigmatism (HP:0000483) | 1.64354210 |
165 | Abnormal social behavior (HP:0012433) | 1.63755074 |
166 | Impaired social interactions (HP:0000735) | 1.63755074 |
167 | Paraplegia (HP:0010550) | 1.62183684 |
168 | Absent speech (HP:0001344) | 1.61607546 |
169 | Birth length less than 3rd percentile (HP:0003561) | 1.61386697 |
170 | Pancreatic fibrosis (HP:0100732) | 1.61037375 |
171 | Deformed tarsal bones (HP:0008119) | 1.60324372 |
172 | Abnormality of chromosome stability (HP:0003220) | 1.58582668 |
173 | Abnormality of the renal medulla (HP:0100957) | 1.57428262 |
174 | Frequent falls (HP:0002359) | 1.57419138 |
175 | Protruding tongue (HP:0010808) | 1.55372862 |
176 | Abnormality of the labia majora (HP:0012881) | 1.54730114 |
177 | Abnormality of the parathyroid morphology (HP:0011766) | 1.54344576 |
178 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.54305131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK19 | 3.82063393 |
2 | BCKDK | 3.80506708 |
3 | EEF2K | 3.52761934 |
4 | TRIB3 | 3.27660283 |
5 | PKN2 | 2.94143786 |
6 | MAPKAPK3 | 2.84717383 |
7 | TAOK3 | 2.49604551 |
8 | ERN1 | 2.49170148 |
9 | PDK3 | 2.32843166 |
10 | PDK4 | 2.32843166 |
11 | TAOK1 | 2.30342530 |
12 | NEK1 | 2.15739943 |
13 | FLT3 | 2.13707435 |
14 | MAP4K2 | 2.06550089 |
15 | MAP2K3 | 2.03136827 |
16 | TTN | 2.01085714 |
17 | WNK3 | 1.98915988 |
18 | ACVR1B | 1.95327154 |
19 | PHKG2 | 1.93307223 |
20 | PHKG1 | 1.93307223 |
21 | SGK2 | 1.90593020 |
22 | FRK | 1.84788506 |
23 | PINK1 | 1.83784242 |
24 | CASK | 1.80363182 |
25 | KSR2 | 1.80204637 |
26 | PNCK | 1.77428099 |
27 | ERBB3 | 1.72058347 |
28 | SCYL2 | 1.62177128 |
29 | SGK494 | 1.60208290 |
30 | SGK223 | 1.60208290 |
31 | MAP3K11 | 1.56954150 |
32 | PIK3CG | 1.56056490 |
33 | EIF2AK1 | 1.55314791 |
34 | MAP4K1 | 1.54659936 |
35 | RIPK1 | 1.49438046 |
36 | CAMK1G | 1.48070490 |
37 | BCR | 1.43115664 |
38 | MUSK | 1.41309987 |
39 | LMTK2 | 1.38999782 |
40 | MAP2K6 | 1.38976190 |
41 | MAPK13 | 1.38591898 |
42 | KIT | 1.37595533 |
43 | NTRK2 | 1.34794396 |
44 | ZAP70 | 1.33828861 |
45 | BRD4 | 1.33183799 |
46 | WEE1 | 1.27776148 |
47 | MARK1 | 1.25378895 |
48 | RPS6KB2 | 1.18228828 |
49 | SGK3 | 1.16790013 |
50 | MAP2K4 | 1.16781518 |
51 | AKT3 | 1.13175097 |
52 | NME2 | 1.10472957 |
53 | BMPR1B | 1.07692158 |
54 | TNIK | 1.06934373 |
55 | CAMK4 | 1.06122190 |
56 | ZAK | 1.06040191 |
57 | DYRK2 | 1.04551900 |
58 | PRKD3 | 1.04458897 |
59 | OBSCN | 1.03304161 |
60 | MAPK11 | 1.02497181 |
61 | CDC7 | 1.02032117 |
62 | MAP3K6 | 1.01063204 |
63 | MAP3K10 | 1.00501452 |
64 | TGFBR1 | 0.99630674 |
65 | ILK | 0.98618138 |
66 | PDK2 | 0.97319180 |
67 | DYRK3 | 0.96634084 |
68 | MAP3K9 | 0.92667661 |
69 | MAP2K7 | 0.91269239 |
70 | NEK2 | 0.89651268 |
71 | ADRBK2 | 0.89645278 |
72 | DMPK | 0.87653849 |
73 | PLK4 | 0.87437339 |
74 | KDR | 0.84241622 |
75 | TESK1 | 0.82879471 |
76 | TAOK2 | 0.82373629 |
77 | CAMK1 | 0.80325578 |
78 | TEC | 0.80288272 |
79 | CCNB1 | 0.79027531 |
80 | MAP3K5 | 0.76911334 |
81 | SGK1 | 0.75907151 |
82 | FGFR4 | 0.75906542 |
83 | PKN1 | 0.75847617 |
84 | CSNK1G2 | 0.75303134 |
85 | NEK9 | 0.74985970 |
86 | MAP3K1 | 0.74484816 |
87 | TBK1 | 0.74393138 |
88 | PIK3CA | 0.74088170 |
89 | BRSK2 | 0.74083068 |
90 | TRIM28 | 0.74043185 |
91 | MAPKAPK5 | 0.73929907 |
92 | INSRR | 0.73797306 |
93 | STK3 | 0.73083396 |
94 | GRK1 | 0.71325594 |
95 | RAF1 | 0.71217043 |
96 | CDK4 | 0.70169924 |
97 | CHEK2 | 0.68741839 |
98 | RET | 0.68665002 |
99 | MAPK12 | 0.68549123 |
100 | STK16 | 0.68353564 |
101 | EPHA3 | 0.68125612 |
102 | MAP3K8 | 0.65546232 |
103 | CAMKK1 | 0.65441081 |
104 | BRSK1 | 0.64318620 |
105 | JAK3 | 0.62854248 |
106 | MAP3K12 | 0.62493636 |
107 | DAPK1 | 0.62096205 |
108 | NLK | 0.62048604 |
109 | STK38L | 0.61050267 |
110 | DYRK1B | 0.60674920 |
111 | LRRK2 | 0.59041504 |
112 | ATM | 0.58283708 |
113 | MATK | 0.58192888 |
114 | CSNK1A1L | 0.57978150 |
115 | BTK | 0.57843977 |
116 | MKNK1 | 0.57741088 |
117 | RPS6KA6 | 0.57511170 |
118 | CAMKK2 | 0.56388687 |
119 | TESK2 | 0.56061858 |
120 | JAK2 | 0.55811013 |
121 | LATS2 | 0.55146651 |
122 | MARK2 | 0.54993253 |
123 | RPS6KA5 | 0.54654199 |
124 | PRKG1 | 0.54268452 |
125 | PRKAA1 | 0.54001848 |
126 | PDK1 | 0.53841601 |
127 | MAP2K2 | 0.53759437 |
128 | STK24 | 0.51892968 |
129 | PASK | 0.51881533 |
130 | EIF2AK3 | 0.50892388 |
131 | ADRBK1 | 0.50594732 |
132 | TSSK6 | 0.50144326 |
133 | PRKAA2 | 0.50040622 |
134 | CAMK1D | 0.49041230 |
135 | MINK1 | 0.48163074 |
136 | CSF1R | 0.47482647 |
137 | IRAK1 | 0.47477019 |
138 | PRKACA | 0.46366709 |
139 | TTK | 0.46235820 |
140 | PAK4 | 0.46177237 |
141 | NTRK3 | 0.45072461 |
142 | MYLK | 0.44540077 |
143 | RPS6KC1 | 0.44462426 |
144 | RPS6KL1 | 0.44462426 |
145 | PRKG2 | 0.43691772 |
146 | RPS6KB1 | 0.43527157 |
147 | MAP3K7 | 0.42403857 |
148 | MAP2K1 | 0.42245300 |
149 | PRKCQ | 0.42154381 |
150 | TIE1 | 0.41671300 |
151 | SIK3 | 0.41606591 |
152 | RPS6KA3 | 0.41605931 |
153 | BUB1 | 0.41329322 |
154 | PIM2 | 0.41046679 |
155 | TYK2 | 0.40314740 |
156 | CSNK1G3 | 0.39875459 |
157 | RPS6KA4 | 0.39167082 |
158 | CDK3 | 0.38979929 |
159 | RPS6KA1 | 0.38766093 |
160 | ARAF | 0.38076984 |
161 | MAP3K4 | 0.37976188 |
162 | CSNK1G1 | 0.37873651 |
163 | BRAF | 0.36352885 |
164 | PTK2B | 0.36144463 |
165 | ATR | 0.35244832 |
166 | MTOR | 0.32391661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.69830237 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.69659762 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04798785 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.86160719 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.71835776 |
6 | Carbon metabolism_Homo sapiens_hsa01200 | 2.61983769 |
7 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.58637855 |
8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.53535170 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43547096 |
10 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.38211757 |
11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.32286213 |
12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.24932569 |
13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23671693 |
14 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 2.11584020 |
15 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.08548402 |
16 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.03105936 |
17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.00880861 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98788007 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98310264 |
20 | Alcoholism_Homo sapiens_hsa05034 | 1.90707673 |
21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.88363981 |
22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.86449930 |
23 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.84813934 |
24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.82180690 |
25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.82088899 |
26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.79775268 |
27 | Phototransduction_Homo sapiens_hsa04744 | 1.72704000 |
28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.65664768 |
29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.60604690 |
30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60558595 |
31 | Base excision repair_Homo sapiens_hsa03410 | 1.56740557 |
32 | Morphine addiction_Homo sapiens_hsa05032 | 1.51054825 |
33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.46855923 |
34 | Mismatch repair_Homo sapiens_hsa03430 | 1.46420080 |
35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46313260 |
36 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45113666 |
37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.37721880 |
38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.37670078 |
39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35841153 |
40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.35767075 |
41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34092696 |
42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32925996 |
43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32815417 |
44 | Cell cycle_Homo sapiens_hsa04110 | 1.31969229 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.31868079 |
46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.30915092 |
47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30656506 |
48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.30646740 |
49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29031447 |
50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24252187 |
51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24226987 |
52 | Long-term depression_Homo sapiens_hsa04730 | 1.23075865 |
53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21351126 |
54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18534477 |
55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.16326544 |
56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15377171 |
57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.12866948 |
58 | Taste transduction_Homo sapiens_hsa04742 | 1.12306633 |
59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11884875 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08640721 |
61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06826026 |
62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04456366 |
63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02553120 |
64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00661051 |
65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00539456 |
66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99842674 |
67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99192444 |
68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98963900 |
69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98756035 |
70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97281667 |
71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95862793 |
72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95686881 |
73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95161550 |
74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95137683 |
75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95027818 |
76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94014323 |
77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92818281 |
78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92711463 |
79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92442350 |
80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92418348 |
81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90362343 |
82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89889207 |
83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87773866 |
84 | Peroxisome_Homo sapiens_hsa04146 | 0.86563170 |
85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86083770 |
86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86057800 |
87 | RNA transport_Homo sapiens_hsa03013 | 0.85112235 |
88 | Insulin resistance_Homo sapiens_hsa04931 | 0.84394154 |
89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82441272 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81963034 |
91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81240174 |
92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80864574 |
93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79250991 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78203975 |
95 | Purine metabolism_Homo sapiens_hsa00230 | 0.77154357 |
96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75923520 |
97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74414193 |
98 | RNA degradation_Homo sapiens_hsa03018 | 0.74304352 |
99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72885570 |
100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71734590 |
101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71722814 |
102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71229901 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71218090 |
104 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71067130 |
105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70836573 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69411285 |
107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68869869 |
108 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68023819 |
109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67015464 |
110 | Renin secretion_Homo sapiens_hsa04924 | 0.66050823 |
111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63814828 |
112 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63447943 |
113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.63288295 |
114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63088290 |
115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62808609 |
116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59958681 |
117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59297124 |
118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58774933 |
119 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58254377 |
120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58207775 |
121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57973771 |
122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57697126 |
123 | Proteasome_Homo sapiens_hsa03050 | 0.56367182 |
124 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.56083057 |
125 | Platelet activation_Homo sapiens_hsa04611 | 0.54685058 |
126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53158551 |
127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52627265 |
128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51599805 |
129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50594478 |
130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50162255 |
131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49478813 |
132 | ABC transporters_Homo sapiens_hsa02010 | 0.49268224 |
133 | Gap junction_Homo sapiens_hsa04540 | 0.49240132 |
134 | Melanoma_Homo sapiens_hsa05218 | 0.48739259 |
135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48708329 |
136 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48629264 |
137 | Bile secretion_Homo sapiens_hsa04976 | 0.47629615 |
138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47308237 |
139 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46816108 |
140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42823307 |
141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42518780 |
142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40878437 |
143 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40407309 |
144 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40231118 |
145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39624647 |
146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39144530 |
147 | Shigellosis_Homo sapiens_hsa05131 | 0.38579886 |
148 | Homologous recombination_Homo sapiens_hsa03440 | 0.37520651 |
149 | Axon guidance_Homo sapiens_hsa04360 | 0.36611313 |
150 | Legionellosis_Homo sapiens_hsa05134 | 0.36502063 |
151 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35828897 |
152 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35067484 |
153 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34897946 |
154 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34769493 |
155 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33898048 |
156 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33597153 |
157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32877936 |
158 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31168131 |
159 | Lysine degradation_Homo sapiens_hsa00310 | 0.30828504 |
160 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30495632 |